Skip to main content

Government News

  • India will bea part of a first-of-its-kind clinical trial for treating spinal cord injury in humans through stem-cells involving 18 patients. The clinical trial is a part of a collaborative study conducted in China, Norway and America involving 240 patients. The pre-clinical trial of this project already completed in the US and also the first phase clinical trials in China involving 120 patients.

  • The Indian pharmaceutical sector would soon be showcasing new drugs for malaria, osteoporosis and diabetes, Union Minister for Science and Technology Harsh Vardhan said. These drugs are currently undergoing clinical trials, he said.

     

    [adsense:336x280:8701650588]

  • Health ministry to amend Form 12-B of D&C Rules; Form 12-B of the Drugs and Cosmetics Rules is  for giving permission for import of small quantities of drugs for personal use. The Union health ministry will soon amend Rules in this regard.

    [adsense:336x280:8701650588]

  • To ensure medicines sold in the country are genuine products, the health ministry has developed a 'Track and Trace' mechanism which will enable consumers to check safety and authenticity of a drug through the internet. Barcode helps in tracking and tracing origin of drugs, which minimises the chances of genuine medicines being considered spurious, sub-standard or counterfeit. The Pharmaceutical  exporters keep demand in front of Union commerce ministry to exempt barcodes on mono cartons as a secondary level packaging on pharmaceuticals and drugs  export consignment  which is to be implemented from April 1, 2015 for tracing and tracking purposes.

  • World Health Organization (WHO) Country office for India in collaboration with the Ministry of Health and Family Welfare, Government of India and National Health Systems Resource Centre (NHSRC), formally announced the commencement of National Health Systems Resource Centre (NHSRC), as the WHO Collaborating Centre for Priority Medical Devices and Health Technology Policy.

  • Shri Ananth Kumar, Union Minister of Chemicals & Fertilizers launched ‘Pharma Jan Samadhan’ scheme which is a web enabled system for redressal of consumers grievances relating to pricing and availability of medicines, created by National Pharmaceutical Pricing Authority (NPPA).

  • To commercialise Ayurvedic medicines, National Research Development Corporation (NRDC) signed a pact with Central Council for Research in Ayurvedic Sciences (CCRAS). The scope of the Memorandum of Agreement (MOA) also includes providing Intellectual Property Rights (IPR) services to CCRAS in India and abroad.

Subscribe to Government News